Amgen drops Vectibix as colon cancer treatment with Avastin

Amgen halted a clinical trial of its Vectibix drug as part of a chemotherapy regimen with Avastin for treating metastatic colorectal cancer, saying the combo actually hindered survival. The company said an interim analysis of the trial results showed a significant negative response when Vectibix was added to the existing treatment of Genentech's Avastin and chemotherapy.

View Full Article in:

MarketWatch · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations